325 related articles for article (PubMed ID: 16751391)
1. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
Andrews AL; Holloway JW; Holgate ST; Davies DE
J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.
Andrews R; Rosa L; Daines M; Khurana Hershey G
J Immunol; 2001 Feb; 166(3):1716-22. PubMed ID: 11160216
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of the interleukin-13 receptor complex.
Andrews AL; Holloway JW; Puddicombe SM; Holgate ST; Davies DE
J Biol Chem; 2002 Nov; 277(48):46073-8. PubMed ID: 12354755
[TBL] [Abstract][Full Text] [Related]
4. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
5. Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
Mueller TD; Zhang JL; Sebald W; Duschl A
Biochim Biophys Acta; 2002 Nov; 1592(3):237-50. PubMed ID: 12421669
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R
Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184
[TBL] [Abstract][Full Text] [Related]
7. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
8. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.
LaPorte SL; Juo ZS; Vaclavikova J; Colf LA; Qi X; Heller NM; Keegan AD; Garcia KC
Cell; 2008 Jan; 132(2):259-72. PubMed ID: 18243101
[TBL] [Abstract][Full Text] [Related]
9. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
10. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13.
Moynihan BJ; Tolloczko B; El Bassam S; Ferraro P; Michoud MC; Martin JG; Laberge S
Respir Res; 2008 Dec; 9(1):84. PubMed ID: 19116009
[TBL] [Abstract][Full Text] [Related]
12. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
[TBL] [Abstract][Full Text] [Related]
14. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
15. A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.
Kraich M; Klein M; Patiño E; Harrer H; Nickel J; Sebald W; Mueller TD
BMC Biol; 2006 Apr; 4():13. PubMed ID: 16640778
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
Kioi M; Kawakami K; Puri RK
Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
[TBL] [Abstract][Full Text] [Related]
18. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.
Daines MO; Tabata Y; Walker BA; Chen W; Warrier MR; Basu S; Hershey GK
J Immunol; 2006 Jun; 176(12):7495-501. PubMed ID: 16751396
[TBL] [Abstract][Full Text] [Related]
19. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts.
Doucet C; Brouty-Boyé D; Pottin-Clemenceau C; Jasmin C; Canonica GW; Azzarone B
Int Immunol; 1998 Oct; 10(10):1421-33. PubMed ID: 9796908
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of human IL-13 and implication for receptor binding.
Moy FJ; Diblasio E; Wilhelm J; Powers R
J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
